Publication | Closed Access

TRPC1 inhibits the proliferation and migration of estrogen receptor-positive Breast cancer and gives a better prognosis by inhibiting the PI3K/AKT pathway

Breast OncologyBreast CancerBetter PrognosisTumor SuppressorRadiation OncologyMedicineCell BiologyCell SignalingTumor MicroenvironmentEndocrine-related CancerPi3k/akt Pathway